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SUMMARY – The aim of this retrospective study (February 2012 – September 2014) was to 
assess the role of head-up tilt-table test in patients with unexplained syncope. It was performed on 
235 patients at Clinical Department of Cardiology, Sestre milosrdnice University Hospital Center. 
Patients were classified according to test indications: group A (convulsive syncope, n=30), group B 
(suspected vasovagal syncope, n=180), and group C (paroxysmal vertigo, n=25). The groups were 
analyzed and compared according to demographic data (age and gender), referral specialist (cardi-
ologist, neurologist, and others), and test results (positive/negative) with specific response (cardio-
inhibitory, vasodepressor, or mixed). Groups A and B were referred most frequently by neurologists 
and cardiologists (p<0.05). The test was positive in 34 (14.5%) of all evaluated patients (5 in group 
A and 29 in group B), of which 13 (38.2%) had cardioinhibitory, 11 (32.4%) mixed and 10 (29.4%) 
vasodepressor response. In the cardioinhibitory subgroup, three patients (23.1%, 2 males/1 female, 
mean age 28.5 years) with normal electroencephalography were on antiepileptics. During head-
up tilt-table testing, they had bradycardia (heart rate 30.0±5.0 beats/min) and prolonged asystole 
(13.7±11.0 seconds) with development of typical convulsions. These three subjects got a permanent 
pacemaker (atrial/ventricular stimulation, heart rate control) and anticonvulsive therapy was slowly 
withdrawn with no syncope recurrence during 24-month follow up. In conclusion, head-up tilt-table 
test has an important role in the evaluation of patients with unexplained syncope and in differential 
diagnosis of vasovagal syncope. The indication for pacemaker implantation, strictly following the 
European Society of Cardiology guidelines, proved to be effective in preventing syncope relapses in 
patients with cardioinhibitory convulsive syncope.
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Introduction
Syncope is defined as a brief and transient loss 
of consciousness and postural tone with spontane-
ous and complete recovery. During syncope, there is 
global cerebral hypoperfusion and loss of conscious-
ness is often preceded by prodromal symptoms, most 
commonly nausea, dizziness, profound sweating, par-
esthesia, blurred vision and tinnitus. Previous studies 
have shown that about 30% of adult population have 
≥1 syncope during lifetime; some studies indicate that 
this ratio is 2:1 in favor of young women1-7. The most 
frequent form of syncope is vasovagal syncope. It is 
mediated by excessive vagal stimulation, or disbalance 
between sympathetic and parasympathetic autonomic 
activity. Vasovagal syncope is classified into cardio-
inhibitory, vasodepressor, and mixed syncope. It oc-
curs repeatedly in predisposed individuals with pre-
cipitating factors such as emotional stress (especially 
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in warm, stifling spaces), fear, extreme fatigue, pain, 
prolonged standing, etc. Other causes of syncope 
include cardiac problems (arrhythmias and struc-
tural heart diseases), orthostatic hypotension and 
orthostatic intolerance syndromes, and neurologic 
(transient ischemic attack, carotid vascular disease, 
migraine, epilepsy, Parkinson’s disease), metabolic 
(hypoglycemia, shock, alcoholism) and psychogenic 
symptoms1-5,8. Convulsive syncope may be accom-
panied by neurologic symptoms (convulsions, eye 
deviation and/or urinary incontinence). Clinical 
semiology can often resemble epileptic seizures. This 
can lead to misdiagnosis, and according to some 
studies, up to 30% of patients taking antiepileptics 
have syncope and not epileptic seizures9-13. Head-up 
tilt-testing (HUTT) is accepted as the gold standard 
for diagnostic procedure of vasovagal syncope14,15. In 
this study, we investigated the following: 1) the role 
of HUTT in patients with unexplained syncope; 2) 
the importance of HUTT in differential diagnosis 
of vasovagal syncope, especially in patients with 
convulsive syncope; and 3) the importance of prop-
er selection of patients for pacemaker implantation 
and its impact on the quality of life improvement by 
stopping syncope recurrences in patients with car-
dioinhibitory convulsive syncope. 
Patients and Methods
This retrospective study was performed in 235 
consecutive patients undergoing HUTT between 
February 2012 and September 2014. The investigation 
was indicated by cardiologists, neurologists, or other 
specialists and performed at Department of Cardiol-
ogy, Sestre milosrdnice University Hospital Center. 
The investigation was performed in accordance with 
ethical standards laid down in the Declaration of 
Helsinki and approved by the appropriate institution-
al  committee. Patients were included independently 
and classified in three groups according to HUTT 
indications, as follows: 1) group A: 30 patients with 
convulsive syncope, 12 of them were currently taking 
antiepileptic drugs (AEDs) because of suspected epi-
lepsy. They all underwent prior thorough electroen-
cephalographic (EEG) evaluation that classified them 
with normal interictal, irritative and epileptic EEG 
findings; 2) group B: 180 patients with suspected vas-
ovagal syncope; and 3) group C: 25 patients with par-
oxysmal vertigo. 
The groups were analyzed and compared according 
to their baseline demographic data (age and gender), 
specialists who referred them, HUTT results (posi-
tive/negative), and responses defined and classified by 
the Vasovagal Syncope International Study (VASIS) 
criteria16, as follows: 1) mixed (VASIS-1): heart rate 
(HR) decreases by >10% but does not decrease to <40 
beats/min for >10 seconds. Blood pressure (BP) falls 
before HR; 2) cardioinhibition (VASIS-2A): mini-
mum HR >40 beats/min for >10 seconds, or asystole 
occurs for <3 seconds. BP falls before HR; 3) severe 
cardioinhibition/asystole (VASIS-2B): minimum HR 
<40 beats/min for >10 seconds, or asystole occurs for 
>3 seconds. BP falls before or coincident with HR; 
and 4) pure vasodepression (VASIS-3): HR does not 
fall >10% from maximum rate during HUTT. 
Additionally, in patients with positive HUTT we 
analyzed symptoms developed during its conduction 
(weakness, loss of consciousness, jerks, tongue bite, 
incontinence, eyeballs and head movement). 
The exclusion criteria were cerebrovascular dis-
eases (chronic cerebrovascular disease, cerebrovascu-
lar malformations), cerebral tumor or bleeding of any 
date, migraine and Parkinson’s disease or dementia, 
confirmed by extensive prior neurological evaluation 
(clinical examination, Doppler ultrasound of carotid 
and vertebrobasilar arteries, computed tomography 
and magnetic resonance imaging brain scan). We also 
excluded patients with previously confirmed psycho-
genic or metabolic disorders. 
The HUTT was performed in accordance with the 
European Society of Cardiology (ESC) guidelines17,18. 
The procedure started with the patient in supine posi-
tion on a special table during 20 minutes. During this 
time, the patient received 0.9% NaCl infusion. Elec-
trocardiographic (ECG) recording and monitoring of 
BP and HR was done every 5 minutes. After that, the 
patient was lifted to vertical position for 60 minutes (or 
until typical symptoms occurred) with ECG record-
ing and measurement of BP and HR every 5 minutes. 
Finally, they were positioned back horizontally and the 
test was finished. 
In accordance with the ESC guidelines17,18, some 
patients fulfilled the criteria for implantation of a 
dual-chamber, rate modulated (DDDR) permanent 
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pacemaker. It was programmed to DDD pacing mode 
and also received rate drop response pacing, a feature 
of the pacemaker that instituted rapid DDD pacing 
if the device detected a rapid decrease in heart rate. 
The programmed option specified that the initial rate 
drop response parameters should be a drop size of 20 
beats, a drop rate of 70/min, and an intervention rate 
of 100/min for 2 minutes. In addition, all pacemakers 
were programmed with a lower rate at 50 bpm and a 
minimum atrioventricular delay of 200 ms to avoid 
inappropriate pacing and to favor spontaneous cardiac 
rhythm. After implantation, patients were scheduled 
for regular check-up at 3 months and then at every 6 
months for the next 2 years. 
Statistical analysis
Qualitative data are presented as absolute numbers 
and percentages. We used χ2-test with Yates correction 
for its analysis. Quantitative data are presented with 
median and interquartile ranges. Differences between 
two groups were tested by Mann-Whitney U test and 
Student’s t-test. Differences among three groups were 
tested by nonparametric analysis of variance (Kruskal-
Wallis ANOVA). The level of statistical significance 
was set at p<0.05. Processing was done using the STA-
TISTICA 6.0 software (StatSoft Inc., USA).
Results
The HUTT was positive in 34 (14.5%) of all study 
subjects (N=235), 14 (41.2%) males and 20 (58.8%) 
females. The following test findings were recorded: 
1) there were no significant differences among three 
groups according to demographic data and HUTT 
results (Table 1). Subjects in groups A and B were 
referred most frequently to the HUTT by neurologists 
and cardiologists (p<0.05), and those in group C by 
other specialists (such as general practitioners) (Fig. 1); 
2) characteristics of patients with positive HUTT 
are presented in Table 2. Most had VASIS-2A/2B, 
and not VASIS-1 or VASIS-3 responses, without sig-
nificant age and gender differences. The test was posi-
tive in five group A patients and 29 group B patients. 
There were significant differences in symptoms during 
HUTT between them, i.e. tonic-clonic jerks and eye 
deviation (p<0.05); and 
3) group B subjects (patients with suspected vas-
ovagal syncope) and group C subjects (patients with 
paroxysmal vertigo) had their diagnosis affirmed with 
HUTT testing. 
We further analyzed group A patients with con-
vulsive clinical semiology. Among 30 group A sub-
jects, there were 12 patients taking AEDs. Out of 
these 12 patients taking AEDs, three (two males/
one female, mean age 28.5 years) patients had posi-
tive HUTT (25%). They had a mean of 2.3±0.6 con-
vulsive syncopes per year, repeatedly normal interictal 
EEG and no prior cardiac problem. During HUTT, 
they developed cardioinhibitory VASIS-2B vasovagal 
response with bradycardia (HR 30.0±5.0 beats/min) 
followed by prolonged asystole (13.7±11.0 seconds). 
Clinically, they all had loss of consciousness with 
tonic-clonic jerks and eyeball deviation with upward 
gaze that lasted until restoration of the normal cardiac 
rhythm. 
In accordance with ESC guidelines17,18, in these 
three patients we implanted a DDDR pacemaker 
(Medtronic Kappa, Medtronic Inc., Minneapolis, 
Table 1. Baseline characteristics of patients undergoing HUTT (N=235)
Findings Parameter Group A (n=30) Group B (n=180) Group C (n=25) Total p value
Demographic 
data
Age† 33.5 (27.0-59.0) 44.5 (29.0-63.5) 45.0 (30.5-52.5) 44.0 (29.0-61.0) 0.490
Male, n (%)‡ 12 (40.0) 64 (35.6) 9 (36.0) 85 (36.2) 0.896
Female, n (%)‡ 18 (60.0) 116 (64.4) 16 (64.0) 150 (63.8) 0.896
HUTT results
Positive, n (%)‡ 5 (16.7) 29 (16.1) 0 (0) 34 (14.5) 0.094
Negative, n (%)‡ 25 (83.3) 151 (83.9) 25 (100) 201 (85.5) 0.094
Group A = patients with convulsive syncope; group B = patients with suspected vasovagal syncope; group C = patients with paroxysmal 
vertigo; HUTT = head-up tilt-table test; †data are presented as median and range, compared with Kruskal-Wallis (ANOVA) test; ‡data 
are presented as absolute number and percentage, compared with χ2-test.
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Fig. 2. Electroencephalographic findings in patients with 
convulsive syncope: 12 patients on antiepileptic drugs (A) 
and 18 patients with no medication (B).
Fig. 1. Comparison of specialist referral to tilt-table 
testing in patients with convulsive syncope (A), suspected 
vasovagal syncope (B) and paroxysmal vertigo (C). 
Table 2. Characteristics of patients with positive HUTT (N=34)
Findings Parameter Group A (n=5) Group B (n=29) Total p value
Demographic 
data
Age† 34.0 (28.0-46.3) 35.0 (24.8-65.0) 34.5 (28.0-65.0) 0.789
Male, n (%)‡ 2 (40.0) 12 (41.4) 14 (41.2) 0.664
Female, n (%)‡ 3 (60.0) 17 (58.6) 20 (58.8) 0.664
HUTT
response 
VASIS-1, n (%)‡ 1 (20.0) 10 (34.5) 11 (32.4) 0.903
VASIS-2A, n (%)‡ 0 (0) 2 (6.9) 2 (5.9) 0.672
VASIS-2B, n (%)‡ 3 (60.0) 8 (27.6) 11 (32.4) 0.361
VASIS-3, n (%)‡ 1 (20.0) 9 (31.0) 10 (29.4) 0.975
Pause, n (%)‡ 3 (60.0) 8 (27.6) 11 (32.4) 0.361




Weakness, n (%)‡ 5 (100) 29 (100) 34 (100) 1.000
Loss of consciousness, n 
(%)‡ 3 (60.0) 7 (24.1) 10 (29.4) 0.274
Tonic-clonic jerks, n (%)‡ 3 (60.0) 0 (0) 3 (8.8) 0.0001
Tongue bite, n (%)‡ 0 (0) 0 (0) 0 (0) -
Incontinence, n (%)‡ 0 (0) 0 (0) 0 (0) -
Eye deviation, n (%)‡ 2 (40.0) 0 (0) 2 (5.9) 0.013
Head movement, n (%)‡ 0 (0) 0 (0) 0 (0) -
Group A = patients with convulsive syncope; group B = patients with suspected vasovagal syncope; HUTT = head-up tilt-table test; VASIS 
= Vasovagal Syncope International Study; VASIS-1 = mixed vasovagal response; VASIS-2A = cardioinhibition/asystole <3.0 sec; VASIS-
2B = severe cardioinhibition/asystole ≥3.0 sec; VASIS-3 = pure vasodepression; †data are presented as median and range, compared with 
Mann-Whitney U test; ‡data are presented as absolute number and percentage, compared with χ2-test; §data are presented as mean ± 
standard deviation, compared with Student’s t-test.
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MN, USA). During 6-month follow up, in two pa-
tients we detected a drop rate 50/min, drop size 50/
min, and a total of 10 pacemaker interventions. In 
one patient, we recorded a drop rate of 55/min, drop 
size of 25/min, and a total of 80 pacemaker interven-
tions, and several episodes of non-sustained ventricle 
tachycardia. After 24-month follow up, none of the 
subjects had any syncope and AEDs were slowly 
withdrawn. Another nine patients taking AEDs had 
negative HUTT. Five (41.7%) patients had normal in-
terictal, one (8.3%) patient epileptic and three patients 
(25.0%) irritative EEG findings (Fig. 2).
Among 18 patients with no specific therapy, there 
were two patients (females, mean age 50.5 years) with 
positive HUTT. They had normal interictal EEG, no 
cardiac disease and no medications. They had VASIS-1 
and VASIS-3 vasovagal response. We suggested them a 
conservative approach (hygienic-dietetic measures and 
avoidance of provoking factors), which was effective 
and they had no syncope recurrence. Another 16 pa-
tients had negative HUTT. Thirteen (72.2%) patients 
had normal interictal and three (16.7%) patients had 
irritative EEG findings (Fig. 2). 
Discussion
In this study, we confirmed the role of HUTT in 
the evaluation of patients with unexplained syncope. 
We demonstrated its importance in differential diag-
nosis of vasovagal syncope, especially in patients with 
convulsive syncope. We also demonstrated the signif-
icance of permanent pacemaker implantation for the 
quality of life by reducing the number of syncopes in 
patients with cardioinhibitory convulsive syncope and 
subsequent withdrawal of AEDs. 
Sandhu et al. found that most patients (72.0%) 
were referred to HUTT by cardiologists19. Several au-
thors report that HUTT may be useful in the evalua-
tion of patients with unexplained syncope20,21. Galeta 
et al. report on 139 (36.6%) patients with VASIS-1, 57 
patients (15.0%) with VASIS-2A/2B and 130 (34.2%) 
patients with VASIS-3 response to HUTT. VASIS-3 
and VASIS-1 responses were the most frequent causes 
of syncope in older and younger subjects, respectively. 
It could be explained with physiological aging, asso-
ciated with reduction of the sympathetic-parasym-
pathetic control of cardiac rhythm. Pietrucha et al. 
found no gender differences in the type of vasovagal 
response to HUTT22. 
We found a slightly lower prevalence of patients 
with positive HUTT testing (14.5%). More fre-
quently we found VASIS-2A/2B than VASIS-3 and 
VASIS-1 response, with no significant age or gender 
differences. 
Current ESC guidelines recommend HUTT for 
differential diagnosis of convulsive syncopes1. Ac-
cording to literature data, up to 25% of patients with 
recurrent loss of consciousness and nonspecific EEG 
findings are taking anticonvulsants because of sus-
pected but not diagnosed epilepsy. A significant mi-
nority of these patients have vasovagal syncope9-13.
Among our 12 patients that were on AEDs, only 
one (8.3%) patient had prior epileptic EEG findings. 
In three (25.0%) patients with normal EEG we de-
tected VASIS-2B response with severe bradycardia 
and asystolic pauses >3.0 seconds. During syncope, 
they had typical symptoms described to epileptolo-
gists. In accordance with diagnostic test responses 
(VASIS-2B) and not responding to hygienic-dietetic 
measures, these patients got indication for implanta-
tion of a permanent DDDR pacemaker. Implanta-
tion of permanent pacemakers in patients with asys-
tole and younger than 40 years is recommended17,18. 
Studies have shown effectiveness of the permanent 
pacemaker implantation, especially a new contrac-
tility-driven DDDR pacing and closed-loop stimu-
lation compared with conventional DDI pacing, in 
these patients1,23-25. This is in accordance with our 
results.
Ruiter and Barrett have reported good results in 
preventing syncope in VASIS-1 and VASIS-3 patients 
by increasing fluid intake and with physical counter-
pressure23. In our two patients with suspected epilepsy 
but normal EEG findings, VASIS-1 and VASIS-3 
vasovagal response, conservative approach was suc-
cessful in preventing syncope recurrence during the 
24-month follow up period. 
Two major mechanisms of transient loss of con-
sciousness are global cerebral hypoperfusion that re-
sults in syncope and asynchronous discharge of cere-
bral neurons that leads to seizure26. In some studies, 
simultaneous EEG monitoring was performed during 
the HUTT and most authors showed diffuse brain 
wave slowing down during a syncopal episode27-31.
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In vasodepressor response, there is an appearance 
of theta waves at the onset of syncope, followed by 
increase in the EEG amplitude with reduction of fre-
quency in delta range. Return to supine position is as-
sociated with restoration of a normal EEG pattern. 
In cardioinhibitory response, there is generalized 
slowing and occurrence of delta activity. A sudden re-
duction of brain activity leads to disappearance of ce-
rebral EEG activity (a ‘flat’ EEG). Upon returning the 
patient to supine position, the EEG slowly returned 
to normal during full recovery of consciousness.
The main limitation of this study was that we did 
not perform prolonged simultaneous EEG/ECG 
monitoring in patients with convulsive syncope. Ac-
cording to other authors, it is important in the di-
agnosis of arrhythmogenic epilepsy in which partial 
epileptic discharges profoundly disrupt normal car-
diac rhythm, including bradyarrhythmias and cardiac 
asystole. The appropriate treatment is double-headed, 
including an antiepileptic drug and implantation of a 
permanent pacemaker32,33. Also, we had a short follow 
up period. 
In conclusion, syncope requires a multidisciplinary 
team and individualized approach. HUTT has an im-
portant role in diagnostic evaluation of patients with 
recurrent unexplained syncope. It is indicated in the 
differential diagnosis of vasovagal syncope, especially 
in patients with syncope accompanied by convulsive 
elements. These subjects will benefit from specific 
therapy, thus improving their quality of life. 
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Sažetak
ULOGA TilT TESTA  U DIFERENCIJALNOJ DIJAGNOSTICI NEOBJAŠNJENE SINKOPE
M. Mornar Jelavić, Z. Babić, H. Hećimović, V. Erceg i H. Pintarić
Cilj ovoga retrospektivnog istraživanja (veljača 2012. – rujan 2014. godine) bio je ispitati ulogu tilt testa u bolesnika s 
neobjašnjenom sinkopom. Provedeno je na 235 bolesnika u Zavodu za kardiologiju KBC-a “Sestre milosrdnice”. Bolesnici 
su klasificirani prema indikaciji za izvođenje testa: skupina A (konvulzivna sinkopa, n=30), skupina B (suspektna vazova-
galna sinkopa, n=180) i skupina C (paroksizmalni vertigo, n=25). Skupine su analizirane i uspoređivane prema njihovim 
demografskim podacima (dob, spol), specijalistima koji su ih uputili na pretragu (kardiolozi, neurolozi, ostali) te rezulta-
tima (pozitivan/negativan) i specifičnim odgovorima (kardionhibicija, vazodepresija ili mješoviti) tilt testa. Skupine A i B 
najčešće je na testiranje uputio neurolog i kardiolog (p<0,05). Test je bio pozitivan u 34 (14,5%) bolesnika (5 u skupini A i 
29 u skupini B), od kojih je 13 (38,2%) imalo kardioinhibicijski, 11 (32,4%) mješoviti i 10 (29,4%) vazodepresivni odgovor. 
U kardioinhibicijskoj podskupini troje bolesnika (23,1%, 2 muškarca/1 žena, srednje dobi 28,5 godina) je imalo normalan 
nalaz elektroencefalografije i uzimali su antiepileptike. Tijekom izvođenja testa zabilježili smo bradikardiju (30,0±5,0 ot-
kucaja/min) i produženu asistoliju (13,7±11,0 sekunda) uz pojavu tipičnih konvulzija. U sve troje bolesnika ugrađen je traj-
ni elektrostimulator (atrijska/ventrikulska stimulacija, kontrola frekvencije) i ukinuta je antikonvulzivna terapija, nakon 
čega su tijekom 24 mjeseca praćenja bili bez recidiva sinkope. U zaključku, tilt test ima važnu ulogu u procjeni bolesnika s 
neobjašnjenom sinkopom i u diferencijalnoj dijagnostici vazovagalne sinkope. Indikacija za ugradnju elektrostimulatora, 
strogo slijedeći smjernice Europskoga kardiološkog društva, pokazala se učinkovitom u sprječavanju recidiva sinkopa u 
bolesnika s kardioinhbicijskom konvulzivnom sinkopom.
Ključne riječi: Sinkopa – dijagnostika; Sinkopa – prevencija i kontrola; Sinkopa, vazovagalna – dijagnostika; Napadaji; Test 
tilt-table; Srčani elektrostimulator; Epilepsija
